BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9284086)

  • 21. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse.
    Wu HE; Hong JS; Tseng LF
    Eur J Pharmacol; 2007 Oct; 571(2-3):145-51. PubMed ID: 17617400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice.
    Bansinath M; Bhargava HN
    Neuropharmacology; 1988 Apr; 27(4):433-7. PubMed ID: 2901674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
    Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
    Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes.
    Lavoie PA; Beauchamp G; Elie R
    Can J Physiol Pharmacol; 1997 Aug; 75(8):983-7. PubMed ID: 9360012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of morphine and nalbuphine on intestinal transit in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):685-9. PubMed ID: 6530907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alprazolam and fluoxetine on morphine sensitization in mice.
    Votava M; Krsiak M; Moravec V
    Physiol Res; 2002; 51(4):417-23. PubMed ID: 12449442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
    Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study.
    Netzer P; Sendensky A; Wissmeyer MP; Baumeler S; Batista C; Scheurer U; Krause T; Reber P; Brenneisen R
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1334-41. PubMed ID: 18808445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal transit following intrathecal or subcutaneous narcotic analgesics.
    Dhasmana KM; Banerjee AK; Erdmann W
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):152-61. PubMed ID: 2884939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats.
    Hagan MM; Holguin FD; Cabello CE; Hanscom DR; Moss DE
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1103-7. PubMed ID: 9408220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abatement of morphine-induced slowing in gastrointestinal transit by Dai-kenchu-to, a traditional Japanese herbal medicine.
    Nakamura T; Sakai A; Isogami I; Noda K; Ueno K; Yano S
    Jpn J Pharmacol; 2002 Feb; 88(2):217-21. PubMed ID: 11928724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone inhibits gastric emptying in the rat.
    Asai T; Power I
    Anesth Analg; 1999 Jan; 88(1):204-8. PubMed ID: 9895093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The possible involvement of alpha-adrenoceptors in the intestinal effect of nalbuphine in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):601-4. PubMed ID: 1964710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of some alpha 2-adrenoceptor agonists and antagonists on gastrointestinal transit in mice: influence of morphine, castor oil and glucose.
    Ali BH; Bashir AA
    Clin Exp Pharmacol Physiol; 1993 Jan; 20(1):1-6. PubMed ID: 8094327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.